#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	9830	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2053	473.0	0	.	n	.	0	C1450T	SNP	1450	1450	C	1692	1692	T	492	T	475	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	9830	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2053	473.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1426	1426	C	576	C	561	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	9830	16S	1529	1529	99.93	16S.l6.c17.ctg.1	2053	473.0	0	HET	.	.	.	C226T	.	226	226	C	468	468	C	556	C,T	409,129	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18442	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3462	529.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1671	1671	A	598	A,G	586,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18442	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3462	529.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	581	C	566	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18442	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3462	529.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	588	A	577	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	18442	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3462	529.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	527	C,A	511,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	1332	folP	855	855	99.88	folP.l15.c30.ctg.1	1719	77.1	1	SNP	p	R229S	1	.	.	685	687	AGC	1139	1141	AGC	137;136;134	A;G;C	136;135;131	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	3856	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3352	114.2	0	.	p	.	0	G95A	NONSYN	283	285	GGC	583	585	GCC	113;113;113	G;C;C	111;112;113	.	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	539	3856	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3352	114.2	1	SNP	p	S91F	1	.	.	271	273	TTC	571	573	TTC	127;125;125	T;T;C	124;122;120	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1182	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1377	85.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	474	476	ACC	127;127;128	A;C;C	123;127;128	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1182	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1377	85.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	672	674	CAC	125;126;129	C,A;A;C	121,1;123;127	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1182	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1377	85.3	0	.	p	.	0	A127fs	FSHIFT	379	379	G	738	738	G	132	G	126	.	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	531	1182	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1377	85.3	1	SNP	p	G45D	0	.	.	133	135	GGC	492	494	GGC	134;132;133	G;G;C,A	131;130;130,1	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	744	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1019	72.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3268	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2901	111.9	0	.	p	.	0	S87N	NONSYN	259	261	AGT	502	504	AAT	144;146;149	A,C;A,G;T	141,1;144,1;147	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3268	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2901	111.9	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1546	1548	GCA	135;135;137	G;C,A;A,C	130;128,1;116,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3268	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2901	111.9	1	SNP	p	D86N	0	.	.	256	258	GAC	499	501	GAC	139;139;141	G;A;C	138;135;141	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3268	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2901	111.9	1	SNP	p	S88P	0	.	.	262	264	TCC	505	507	TCC	149;150;148	T,G;C;C	142,1;146;147	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	2818	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2791	100.3	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1619	1621	GGC	152;151;151	G;G;C	149;149;145	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	A311V	0	.	.	931	933	GCA	1386	1388	GCA	170;170;170	G;C;A	164;166;167	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	I312M	0	.	.	934	936	ATC	1389	1391	ATC	169;170;172	A;T;C	167;167;166	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	V316P	0	.	.	946	948	GTG	1401	1403	GTG	167;161;159	G;T;G	166;156;156	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	V316T	0	.	.	946	948	GTG	1401	1403	GTG	167;161;159	G;T;G	166;156;156	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1905	1907	ACC	128;129;129	A;C;C,A	127;127;127,1	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1959	1961	GCG	128;129;129	G;C,G;G	121;116,2;121	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1959	1961	GCG	128;129;129	G;C,G;G	121;116,2;121	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2082	2084	GGT	98;96;93	G;G;T	97;95;90	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2091	2093	GGC	92;90;89	G;G;C	89;89;87	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	2818	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2628	106.6	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2109	2111	CCG	72;72;74	C;C;GCCC,GCCCCC	66;67;68,1	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4000	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3158	126.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1723	1725	CCG	140;141;138	C;C;G,C	129;136;130,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1794	porA	1146	1146	99.65	porA.l15.c30.ctg.1	1747	101.5	0	.	p	.	0	M83fs	FSHIFT	247	247	A	601	601	C	105	C	99	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	V258L	NONSYN	772	774	GTA	98	100	TTA	38;40;40	T;T;A	37;39;38	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	143	145	CAT	29;28;28	C,G;A;T	28,1;28;28	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	D274S	NONSYN	820	822	GAT	146	148	AGT	28;28;28	A;G;T	27;28;27	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	155	157	TAC	30;30;30	T;A;C	29;29;30	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	R307E	NONSYN	919	921	AGA	245	247	GAA	9;9;10	G;A;A	9;9;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	T311A	NONSYN	931	933	ACA	257	259	GCA	9;9;9	G;C;A	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	F314I	NONSYN	940	942	TTC	266	268	ATC	8;8;8	A;T;C	8;8;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	A316S	NONSYN	946	948	GCG	272	274	TCG	7;7;8	T;C;G	7;7;8	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	V318A	NONSYN	952	954	GTC	278	280	GCC	9;9;9	G;C;C	8;8;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	G319S	NONSYN	955	957	GGC	281	283	AGC	9;9;9	A;G;C	9;9;9	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	G320A	NONSYN	958	960	GGT	284	286	GCC	10;10;10	G;C;C	10;10;10	.	.
porB1a.WHO_F_02106	porB1a.WHO_F_02106	1	0	528	238	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	444	17.7	0	.	p	.	0	G322V	NONSYN	964	966	GGT	290	292	GTT	9;9;9	G;T;T	9;9;9	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	0	.	p	.	0	R143G	NONSYN	427	429	AGA	668	670	GGA	146;147;146	G;G,A;A	143;146,1;141	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	0	.	p	.	0	.	INDELS	629	630	AA	871	873	TAG	151;150;147	T;A;G	144;146;140	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	0	.	p	.	0	.	MULTIPLE	631	633	TAC	875	878	CAAT	144;143;147;149	C;A,T;A;T	139;139,1;144;144	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	0	.	p	.	0	N212fs	FSHIFT	634	634	A	880	880	T	152	T,A	147,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	1	SNP	p	G120K	0	.	.	358	360	GGT	599	601	GGT	145;145;145	G;G;T,C	142;143;128,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	1	SNP	p	A121N	0	.	.	361	363	GCC	602	604	GCC	143;141;140	G,A;C,G;C	138,1;137,1;138	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	1960	porB1b	1035	1035	98.94	porB1b.l15.c30.ctg.1	1422	135.3	1	SNP	p	A121D	0	.	.	361	363	GCC	602	604	GCC	143;141;140	G,A;C,G;C	138,1;137,1;138	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	6966	rpoB	4179	4179	99.98	rpoB.l15.c30.ctg.1	4986	139.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2023	2025	AAT	148;149;151	A;A;T	145;147;148	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	838	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1040	79.8	1	SNP	p	V57M	1	.	.	169	171	ATG	510	512	ATG	158;158;156	A;T;G	154;154;153	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	M177T	NONSYN	529	531	ATG	961	963	ACG	283;280;283	A;C;G	279;276;278	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	982	984	GAC	268;265;265	G;A;C	267;264;264	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1000	1002	ATG	260;257;257	A;T;G	260;256;256	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1012	1014	TCA	264;266;266	T;C;A	261;263;266	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1057	1059	CAG	295;297;299	C;A;G	293;296;298	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1078	1080	CTT	285;283;277	C;T;T	284;283;276	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1099	1101	AGT	272;273;273	A;G;T	270;272;263	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1168	1170	CCG	309;307;311	C;C,A;G	303;299,1;305	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1270	1272	TCG	307;306;308	T;C;G,A	304;302;303,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1441	1443	AAA	192;195;194	A;A;A,C	190;193;191,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1444	1446	AAG	189;186;186	A;A;G	186;183;183	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1459	1461	CAC	174;178;175	C;A,C;C	171;174,1;173	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1498	1500	GAA	183;182;183	G;A;A	181;182;183	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1576	1578	ACG	128;129;128	A;C;G	127;129;127	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1627	1629	ATT	155;155;156	A;T;T	153;153;154	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1630	1632	AGT	157;155;156	A;G;T	155;153;152	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1669	1671	CTA	164;165;167	C;T;A	159;159;163	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1711	1713	AAT	129;128;127	A;A;T	128;125;125	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1780	1782	TCA	166;169;170	T,A;C;A	163,1;167;165	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1804	1806	ATG	183;185;185	A;T;G	183;185;184	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2098	2100	ACC	393;395;392	A;C;C,T	382;387;380,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	6988	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2683	259.4	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2194	2196	GAA	395;397;394	G;A;A	390;392;390	.	Tetracycline resistance
